HRMY — Harmony Biosciences Holdings Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareAdventurousMid CapContrarian

Annual balance sheet for Harmony Biosciences Holdings, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st	2025 December 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	234	323	353	467	775
Net Total Accounts Receivable
Net Total Receivables	34.8	54.7	74.1	83	96.8
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	284	400	451	579	907
Net Property, Plant And Equipment	0.82	2.88	2.71	3.38	5.34
Net Intangible Assets
Long Term Investments
Other Long Term Assets
Total Assets	433	674	811	999	1,272
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	53.8	78.9	164	175	252
Long Term Debt
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	247	271	344	340	401
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	187	403	467	659	870
Total Liabilities & Shareholders' Equity	433	674	811	999	1,272
Total Common Shares Outstanding